HIV Vaccine Designed for HIV Infected Adults Taking Anti-HIV Drugs

Summary

This study will evaluate the safety of and immune responses to a dendritic cell vaccination for HIV-1 infection. The vaccine will be made from a patient's own cells combined with small fragments of HIV-1 (made synthetically in a laboratory). These cells will be administered back to the patient either into a vein (intravenously) or the skin (subcutaneously).

Timeline

Start

2003-02

Primary completion

—

Completion

—

Drugs

Indications